Prebiotics for PTSD and cirrhosis
Part of Digestive system, Mental health clinical trials.
This trial tests if a prebiotic supplement can improve gut health and PTSD symptoms in people with cirrhosis and PTSD. It aims to see if changing the gut microbiome can help both conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a cirrhosis diagnosis.
- You must have a confirmed PTSD diagnosis from a mental health provider and meet the PCL-5 criteria.
- You must be willing to take an oral supplement and provide blood or stool samples.
- You cannot have used antibiotics, probiotics, or other gut-related supplements in the last 30 days.
- You cannot have serious conditions like inflammatory bowel disease, Crohn's disease, or celiac disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a special type of starch (resistant potato starch) can help people with cirrhosis who have had episodes of confusion from liver problems. It may help by changing the bacteria in your gut, which could reduce the risk of future confusion episodes.
This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.
This trial tests whether a medication called psilocybin (the active ingredient in magic mushrooms) can help people with long-term PTSD when combined with a specific type of talk therapy. The goal is to see if this approach reduces PTSD symptoms more than therapy alone.
This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.
This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.
This Phase 2/3 study tests whether glecaprevir/pibrentasvir can reduce post-traumatic stress disorder (PTSD) symptoms. It may help Veterans whose PTSD is still affecting daily life, alongside any allowed standard care.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.